Non-invasive Imaging of High-risk Coronary Plaque: the Role of Computed Tomography and Positron Emission Tomography
Overview
Affiliations
Despite recent advances, cardiovascular disease remains the leading cause of death globally. As such, there is a need to optimise our current diagnostic and risk stratification pathways in order to better deliver individualised preventative therapies. Non-invasive imaging of coronary artery plaque can interrogate multiple aspects of coronary atherosclerotic disease, including plaque morphology, anatomy and flow. More recently, disease activity is being assessed to provide mechanistic insights into atherosclerosis biology. Molecular imaging using positron emission tomography is unique in this field, with the potential to identify specific biological processes using either bespoke or re-purposed radiotracers. This review provides an overview of non-invasive vulnerable plaque detection and molecular imaging of coronary atherosclerosis.
Chronic Coronary Artery Disease: Wall Disease vs. Lumenopathy.
Paraskevaidis I, Kourek C, Tsougos E Biomolecules. 2025; 15(2).
PMID: 40001504 PMC: 11852618. DOI: 10.3390/biom15020201.
Imaging patients with stable chest pain special feature: introductory editorial.
Oudkerk M, van Beek E Br J Radiol. 2020; 93(1113):20209005.
PMID: 32815396 PMC: 7465861. DOI: 10.1259/bjr.20209005.